A nurse is reinforcing teaching with a middle adult female client who has fibrocystic breast disease. The nurse should emphasize to the client that manifestations of this disease are present at which of the following times?

A. "Many herbal products have not undergone long-term testing for safety and efficacy.": This statement acknowledges the client's interest in herbal therapies while also providing important information about the potential risks associated with their use.
B. "Herbal therapies have no benefits and will not help your symptoms.": This statement is overly dismissive and may not be accurate, as some herbal therapies have been shown to provide symptom relief for menopausal symptoms.
C. "That is a good idea, as there are no ill effects associated with the use of herbal therapies.": This statement is inaccurate, as herbal therapies can have side effects and interactions with other medications.
D. "You should begin immediately, as they will help you.": This statement is not appropriate as it provides an unqualified endorsement of herbal therapies without considering potential risks or
individual circumstances.

A. Skin color: While changes in skin color can occur in hemochromatosis due to excess iron deposition, it is not the most important parameter to monitor for the effectiveness of deferoxamine.
B. Liver function: Liver function tests can be abnormal in hemochromatosis due to iron overload, but monitoring liver function alone may not adequately assess the effectiveness of deferoxamine in reducing iron levels.
C. Hematocrit: Hematocrit measures the proportion of blood that is made up of red blood cells and may be elevated in hemochromatosis, but it is not the primary parameter to monitor the effectiveness of deferoxamine.
D. Serum iron level: Serum iron level is the most direct indicator of iron overload and the effectiveness of deferoxamine in chelating and removing excess iron from the body.